메뉴 건너뛰기




Volumn 12, Issue , 2017, Pages 2639-2646

Differences in systemic inflammation between cigarette and biomass smoke-induced COPD

Author keywords

Biomass smoke; COPD; Cytokines; Inflammation; Smoking

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CIGARETTE SMOKE; FIBRINOGEN; IMMUNOGLOBULIN E; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; NITRIC OXIDE; SPHINGOLIPID ACTIVATOR PROTEIN 2; TRANSCRIPTION FACTOR RUNX2; TUMOR NECROSIS FACTOR; AUTACOID;

EID: 85029185936     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S141068     Document Type: Article
Times cited : (43)

References (34)
  • 1
    • 77954731213 scopus 로고    scopus 로고
    • Is exposure to biomass smoke the biggest risk factor for COPD globally?
    • Salvi S, Barnes PJ. Is exposure to biomass smoke the biggest risk factor for COPD globally? Chest. 2010;138:3-6.
    • (2010) Chest , vol.138 , pp. 3-6
    • Salvi, S.1    Barnes, P.J.2
  • 2
    • 78349241777 scopus 로고    scopus 로고
    • Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers
    • Sood A, Petersen H, Blanchette CM, et al. Wood smoke exposure and gene promoter methylation are associated with increased risk for COPD in smokers. Am J Respir Crit Care Med. 2010;182(9):1098-1104.
    • (2010) Am J Respir Crit Care Med , vol.182 , Issue.9 , pp. 1098-1104
    • Sood, A.1    Petersen, H.2    Blanchette, C.M.3
  • 4
    • 85003032035 scopus 로고    scopus 로고
    • On-Sint Study Investigators. Occupational and biomass exposure in chronic obstructive pulmonary disease: Results of a cross-sectional analysis of the On-Sint study
    • López-Campos JL, Fernández-Villar A, Calero-Acuña C, et al; On-Sint Study Investigators. Occupational and biomass exposure in chronic obstructive pulmonary disease: results of a cross-sectional analysis of the On-Sint study. Arch Bronconeumol. 2017;53:7-12.
    • (2017) Arch Bronconeumol , vol.53 , pp. 7-12
    • López-Campos, J.L.1    Fernández-Villar, A.2    Calero-Acuña, C.3
  • 5
    • 84922394855 scopus 로고    scopus 로고
    • FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure
    • Ramírez-Venegas A, Sansores RH, Quintana-Carrillo RH, et al. FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure. Am J Respir Crit Care Med. 2014;190(9): 996-1002.
    • (2014) Am J Respir Crit Care Med , vol.190 , Issue.9 , pp. 996-1002
    • Ramírez-Venegas, A.1    Sansores, R.H.2    Quintana-Carrillo, R.H.3
  • 6
    • 84895525357 scopus 로고    scopus 로고
    • COPD phenotypes in biomass smokeversus tobacco smoke-exposed Mexican women
    • Camp PG, Ramírez-Venegas A, Sansores RH, et al. COPD phenotypes in biomass smokeversus tobacco smoke-exposed Mexican women. Eur Respir J. 2014;43(3):725-734.
    • (2014) Eur Respir J , vol.43 , Issue.3 , pp. 725-734
    • Camp, P.G.1    Ramírez-Venegas, A.2    Sansores, R.H.3
  • 7
    • 84871410896 scopus 로고    scopus 로고
    • A comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung
    • Mehra D, Geraghty PM, Hardigan AA, Foronjy R. A comparison of the inflammatory and proteolytic effects of dung biomass and cigarette smoke exposure in the lung. PLoS One. 2012;7(12):e52889.
    • (2012) Plos One , vol.7 , Issue.12
    • Mehra, D.1    Geraghty, P.M.2    Hardigan, A.A.3    Foronjy, R.4
  • 8
    • 84942521088 scopus 로고    scopus 로고
    • Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profile
    • Solleiro-Villavicencio H, Quintana-Carrillo R, Falfán-Valencia R, Vargas-Rojas MI. Chronic obstructive pulmonary disease induced by exposure to biomass smoke is associated with a Th2 cytokine production profile. Clin Immunol. 2015;161(2):150-155.
    • (2015) Clin Immunol , vol.161 , Issue.2 , pp. 150-155
    • Solleiro-Villavicencio, H.1    Quintana-Carrillo, R.2    Falfán-Valencia, R.3    Vargas-Rojas, M.I.4
  • 9
    • 84904466626 scopus 로고    scopus 로고
    • Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke
    • Golpe R, Sanjuán-López P, Cano-Jiménez E, Castro-Añón O, Pérez-de-Llano LA. Distribution of clinical phenotypes in patients with chronic obstructive pulmonary disease caused by biomass and tobacco smoke. Arch Bronconeumol. 2014;50:318-324.
    • (2014) Arch Bronconeumol , vol.50 , pp. 318-324
    • Golpe, R.1    Sanjuán-López, P.2    Cano-Jiménez, E.3    Castro-Añón, O.4    Pérez-De-Llano, L.A.5
  • 10
    • 84861410475 scopus 로고    scopus 로고
    • ECLIPSE Investigators. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease
    • Celli BR, Locantore N, Yates J, et al; ECLIPSE Investigators. Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;185(10): 1065-1072.
    • (2012) Am J Respir Crit Care Med , vol.185 , Issue.10 , pp. 1065-1072
    • Celli, B.R.1    Locantore, N.2    Yates, J.3
  • 13
    • 30844433530 scopus 로고    scopus 로고
    • C-reactive protein in patients with COPD, control smokers and non-smokers
    • Pinto-Plata VM, Müllerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax. 2006; 61(1):23-28.
    • (2006) Thorax , vol.61 , Issue.1 , pp. 23-28
    • Pinto-Plata, V.M.1    Müllerova, H.2    Toso, J.F.3
  • 14
    • 85029173404 scopus 로고    scopus 로고
    • Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure
    • Vargas-Rojas MI, Solleiro-Villavicencio H, Ramírez-Venegas A, Velázquez-Uncal M, Quintana R, Sansores-Martínez R. Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure. Eur Respir J. 2013;42(Suppl 57):595.
    • (2013) Eur Respir J , vol.42 , Issue.57 , pp. 595
    • Vargas-Rojas, M.I.1    Solleiro-Villavicencio, H.2    Ramírez-Venegas, A.3    Velázquez-Uncal, M.4    Quintana, R.5    Sansores-Martínez, R.6
  • 15
    • 34548277025 scopus 로고    scopus 로고
    • From COPD to chronic systemic inflammatory syndrome?
    • Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome? Lancet. 2007;370:797-799.
    • (2007) Lancet , vol.370 , pp. 797-799
    • Fabbri, L.M.1    Rabe, K.F.2
  • 16
    • 84903342775 scopus 로고    scopus 로고
    • FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure
    • Montaño M, Sansores RH, Becerril C, et al. FEV1 inversely correlates with metalloproteinases 1, 7, 9 and CRP in COPD by biomass smoke exposure. Respir Res. 2014;15:74.
    • (2014) Respir Res. , vol.15 , pp. 74
    • Montaño, M.1    Sansores, R.H.2    Becerril, C.3
  • 17
    • 33645450879 scopus 로고    scopus 로고
    • IL-6 haplotypes, inflammation and risk for cardiovascular disease in a multiethnic dialysis cohort
    • Liu Y, Berthier-Schaad Y, Fallin MD, et al. IL-6 haplotypes, inflammation and risk for cardiovascular disease in a multiethnic dialysis cohort. J Am Soc Nephrol. 2006;17:863-870.
    • (2006) J am Soc Nephrol , vol.17 , pp. 863-870
    • Liu, Y.1    Berthier-Schaad, Y.2    Fallin, M.D.3
  • 18
    • 84875847989 scopus 로고    scopus 로고
    • Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease
    • Van Fleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728-735.
    • (2013) Am J Respir Crit Care Med , vol.187 , Issue.7 , pp. 728-735
    • Van Fleteren, L.E.1    Spruit, M.A.2    Groenen, M.3
  • 20
    • 85018758740 scopus 로고    scopus 로고
    • Prevalence of major comorbidities in chronic obstructive pulmonary disease caused by biomass smoke or tobacco
    • Golpe R, Martín-Robles I, Sanjuán-López P, et al. Prevalence of major comorbidities in chronic obstructive pulmonary disease caused by biomass smoke or tobacco. Respiration. 2017;94(1):38-44.
    • (2017) Respiration , vol.94 , Issue.1 , pp. 38-44
    • Golpe, R.1    Martín-Robles, I.2    Sanjuán-López, P.3
  • 21
    • 15744363493 scopus 로고    scopus 로고
    • An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema
    • Grumelli S, Corry DB, Song LZ, et al. An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema. PLoS Med. 2004;1(1):e8.
    • (2004) Plos Med , vol.1 , Issue.1
    • Grumelli, S.1    Corry, D.B.2    Song, L.Z.3
  • 22
    • 84860655039 scopus 로고    scopus 로고
    • Innate and adaptive immune responses in asthma
    • Holgate ST. Innate and adaptive immune responses in asthma. Nat Med. 2012;18(5):673-683.
    • (2012) Nat Med , vol.18 , Issue.5 , pp. 673-683
    • Holgate, S.T.1
  • 24
    • 67650653218 scopus 로고    scopus 로고
    • T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients
    • Di Stefano A, Caramori G, Gnemmi I, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol. 2009;157(2): 316-324.
    • (2009) Clin Exp Immunol , vol.157 , Issue.2 , pp. 316-324
    • Di Stefano, A.1    Caramori, G.2    Gnemmi, I.3
  • 27
    • 84901313491 scopus 로고    scopus 로고
    • Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: Evidence of a gender effect
    • Faner R, González N, Cruz T, Graciela-Kalko S, Agustí A. Systemic inflammatory response to smoking in chronic obstructive pulmonary disease: evidence of a gender effect. PLoS One. 2014;9(5):e97491.
    • (2014) Plos One , vol.9 , Issue.5
    • Faner, R.1    González, N.2    Cruz, T.3    Graciela-Kalko, S.4    Agustí, A.5
  • 28
    • 84895526445 scopus 로고    scopus 로고
    • Source of biomass cooking fuel determines pulmonary response to household air pollution
    • Sussan TE, Ingole V, Kim JH, et al. Source of biomass cooking fuel determines pulmonary response to household air pollution. Am J Respir Cell Mol Biol. 2014;50(3):538-548.
    • (2014) Am J Respir Cell Mol Biol , vol.50 , Issue.3 , pp. 538-548
    • Sussan, T.E.1    Ingole, V.2    Kim, J.H.3
  • 29
    • 84927656001 scopus 로고    scopus 로고
    • Clinical characteristics and airway inflammation profile of COPD persistent sputum producers
    • Khurana S, Ravi A, Sutula J, et al. Clinical characteristics and airway inflammation profile of COPD persistent sputum producers. Respir Med. 2014;108(12):1761-1770.
    • (2014) Respir Med , vol.108 , Issue.12 , pp. 1761-1770
    • Khurana, S.1    Ravi, A.2    Sutula, J.3
  • 30
    • 84867116844 scopus 로고    scopus 로고
    • Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum and induced sputum
    • Röpcke S, Holz O, Lauer G, et al. Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum and induced sputum. PLoS One. 2012;7(10):e46207.
    • (2012) Plos One , vol.7 , Issue.10
    • Röpcke, S.1    Holz, O.2    Lauer, G.3
  • 31
    • 85027224628 scopus 로고    scopus 로고
    • Miembros del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la EPOC (PAC-COPD). Lack of correlation between pulmonary and systemic inflammation markers in patients with chronic obstructive pulmonary disease: A simultaneous, two-compartmental analysis
    • Núñez B, Sauleda J, Garcia-Aymerich J, et al; Miembros del Grupo de Trabajo sobre la Caracterización Fenotípica y Evolución de la EPOC (PAC-COPD). Lack of correlation between pulmonary and systemic inflammation markers in patients with chronic obstructive pulmonary disease: a simultaneous, two-compartmental analysis. Arch Bronconeumol. 2016;52:361-367.
    • (2016) Arch Bronconeumol , vol.52 , pp. 361-367
    • Núñez, B.1    Sauleda, J.2    Garcia-Aymerich, J.3
  • 32
    • 84955590088 scopus 로고    scopus 로고
    • Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values
    • Akiki Z, Fakih D, Jounblat R, et al. Surfactant protein D, a clinical biomarker for chronic obstructive pulmonary disease with excellent discriminant values. Exp Ther Med. 2016;11(3):723-730.
    • (2016) Exp Ther Med , vol.11 , Issue.3 , pp. 723-730
    • Akiki, Z.1    Fakih, D.2    Jounblat, R.3
  • 33
    • 84862100999 scopus 로고    scopus 로고
    • Evaluation of COPD longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: A novel phenotype
    • Agustí A, Edwards LD, Rennard SI, et al; Evaluation of COPD longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One. 2012; 7(5):e37483.
    • (2012) Plos One , vol.7 , Issue.5
    • Agustí, A.1    Edwards, L.D.2    Rennard, S.I.3
  • 34
    • 77957719327 scopus 로고    scopus 로고
    • On behalf of the Environmental and Occupational Health Assembly Committee on Nonsmoking COPD. An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease
    • Eisner MD, Anthonisen N, Coultas D, et al; on behalf of the Environmental and Occupational Health Assembly Committee on Nonsmoking COPD. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5): 693-718
    • (2010) Am J Respir Crit Care Med , vol.182 , Issue.5 , pp. 693-718
    • Eisner, M.D.1    Anthonisen, N.2    Coultas, D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.